Quick Answer
Can-Fite BioPharma Ltd. reported Shares Outstanding of 2.62 million shares for fiscal year 2025.
Can-Fite BioPharma Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.62M | +163.3% |
| 2024 | 994,394 | -99.9% |
| 2023 | 1.36B | +66.7% |
| 2022 | 815.75M | +0.0% |
| 2021 | 815.75M | +75.9% |
| 2020 | 463.77M | +284.4% |
| 2019 | 120.65M | — |
- Can-Fite BioPharma Ltd. showed an increase of +163.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Can-Fite BioPharma Ltd.’s shares outstanding has declined by 97.8% (from 120.65 million shares to 2.62 million shares).
- The most recent figure is from Can-Fite BioPharma Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: